Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can arginine and glutamine soothe radiation mouth pain?

NCT ID NCT07020754

First seen Feb 02, 2026 · Last updated Jun 19, 2026 · Updated 21 times

Summary

This study tested whether mouth rinses containing the amino acids arginine or glutamine could reduce the severity of painful mouth sores caused by radiation therapy in head and neck cancer patients. 69 participants swished and swallowed these supplements three times daily during weeks 2 to 7 of their radiation treatment. Researchers measured inflammation markers, pain levels, and quality of life to see if either supplement helped more than a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL MUCOSITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Faculty of Dentistry, Future University in Egypt

    Cairo, Cairo Governorate, 10226, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

L-arginine and L-glutamine oral suspensions

What this could lead to

If effective, these amino acid mouth rinses could offer a simple, low-cost way to reduce pain and speed healing of radiation-induced mouth sores.

What could go wrong

This is a small Phase 2 trial with only 69 participants, so results may not apply to everyone. The supplements may not outperform the placebo, and any benefit might be modest.

Conditions

The condition(s) this trial relates to.

chemotherapy-induced oral mucositis head and neck cancer Head and Neck Neoplasms stomatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.